Skip to main content

Table 1 Comparisons of the clinical and initial CT findings between the AA-group, CP-group and CS-group with phlebosclerotic colitis

From: Phlebosclerotic colitis: an analysis of clinical and CT findings in 29 patients with long-term follow-up

 

AA-group (n = 10)

CP-group (n = 14)

CS-group (n = 5)

P1

P2

P3

P4

Clinical findings

Age (years) (mean ± SD)

58.1 ± 14.5

62.0 ± 7.3

58.0 ± 9.8

NS

   

Gender, female, n (%)

7 (70%)

11 (76%)

4 (80%)

NS

   

Diabetes (+), n (%)

1 (10%)

6 (43%)

0 (0%)

NS

   

Chronic renal failure (+), n (%)

2 (20%)

10 (71%)

1 (20%)

0.011

0.005

NS

NS

Urotract malignancies (+), n (%)

2 (20%)

9 (64%)

1 (20%)

0.017

0.008

NS

NS

Liver cirrhosis (+), n (%)

2 (20%)

9 (64%)

1 (20%)

0.017

0.008

NS

NS

Hepatocellular carcinoma (+), n (%)

2 (20%)

2 (14%)

0 (0%)

NS

   

Herbal medicine > 5 years (+), n (%)

2 (20%)

3 (21%)

1 (20%)

NS

   

Follow-up duration (years) (mean ± SD)

7.1 ± 3.3

7.9 ± 4.3

8.2 ± 3.9

NS

   

Initial CT findings

PC calcification scores (mean ± SD)

23.5 ± 8.4

14.7 ± 10.9

11.8 ± 5.7

0.046*

NS

NS

NS

MWT(mm) (mean ± SD)

10.5 ± 3.4

2.3 ± 1.2

1.6 ± 0.5

< 0.001*

< 0.001§

0.001§

NS

PC segments (mean ± SD)

4.0 ± 0.8

2.4 ± 1.7

2.2 ± 1.1

0.047*

0.031§

0.028§

NS

Pericolic inflammation (+), n (%)

10 (100%)

0 (0%)

0 (0%)

< 0.001

< 0.001

< 0.001

NS

  1. PC, phlebosclerotic colitis; MWT, maximum colonic wall thickness; (+), positive; NS, not significant
  2. P1: *Kruskal–Wallis test (numeric) or Chi-square test (nominal) for 3 groups. If P1 < 0.05, further analysis using the §Mann–Whitney U test with Bonferroni correction or Chi-square test
  3. P2: AA- vs CP-groups, P3: AA-vs CS-groups, P4: CP- vs CS-groups